Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2001 Mar;56(3):212–217. doi: 10.1136/thorax.56.3.212

Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study

A Gregor 1, C Thomson 1, D Brewster 1, P Stroner 1, J Davidson 1, R Fergusson 1, R Milroy 1
PMCID: PMC1758769  PMID: 11182014

Abstract

BACKGROUND—The prognosis of patients with lung cancer in Scotland is poor and not improving. This study was designed to document factors influencing referral, diagnostic evaluation, treatment, and survival in patients with lung cancer.
METHODS—Patients diagnosed during 1995 were identified from the Scottish Cancer Registry and their medical records were reviewed. Adequate records were available in 91.2% of all potentially eligible cases.
RESULTS—In 1995, patients in Scotland with lung cancer had a high rate of microscopic verification (74.1%) and 75.3% were assessed by a respiratory physician; however, only 56.8% received active treatment (resection 10.7%, radiotherapy 35.8%, chemotherapy 16.1%) and 2.9% participated in a clinical trial. Survival was poor with a median of 3.6 months; 21.1% (95% CI 19.8% to 22.4%) were alive at 1 year and 7.0% (95% CI 6.2% to 7.8%) at 3 years. Management by respiratory physician, oncologist, or thoracic surgeon was an independent predictor of access to potentially curative treatment and better survival.
CONCLUSION—This national population based study demonstrates low use of treatment, poor survival, and the influence of process of care on survival. Implementation of evidence-based guidelines will require substantial changes in practice. Increasing the number of patients who receive treatment may improve survival.



Full Text

The Full Text of this article is available as a PDF (152.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aupérin A., Arriagada R., Pignon J. P., Le Péchoux C., Gregor A., Stephens R. J., Kristjansen P. E., Johnson B. E., Ueoka H., Wagner H. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med. 1999 Aug 12;341(7):476–484. doi: 10.1056/NEJM199908123410703. [DOI] [PubMed] [Google Scholar]
  2. Brewster D. H., Crichton J., Harvey J. C., Dawson G. Completeness of case ascertainment in a Scottish regional cancer registry for the year 1992. Public Health. 1997 Sep;111(5):339–343. doi: 10.1016/s0033-3506(97)00065-6. [DOI] [PubMed] [Google Scholar]
  3. Brewster D., Muir C., Crichton J. Registration of lung cancer in Scotland: an assessment of data accuracy based on review of medical records. Cancer Causes Control. 1995 Jul;6(4):303–310. doi: 10.1007/BF00051405. [DOI] [PubMed] [Google Scholar]
  4. Brown J. S., Eraut D., Trask C., Davison A. G. Age and the treatment of lung cancer. Thorax. 1996 Jun;51(6):564–568. doi: 10.1136/thx.51.6.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Connolly C. K., Jones W. G., Thorogood J., Head C., Muers M. F. Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire Region of England 1976-1983. Br J Cancer. 1990 Apr;61(4):579–583. doi: 10.1038/bjc.1990.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dales R. E., Stark R. M., Raman S. Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis. Am Rev Respir Dis. 1990 May;141(5 Pt 1):1096–1101. doi: 10.1164/ajrccm/141.5_Pt_1.1096. [DOI] [PubMed] [Google Scholar]
  7. Feld R., Abratt R., Graziano S., Jassem J., Lacquet L., Ninane V., Paesmans M., Rocmans P., Schiepers C., Stahel R. Pretreatment minimal staging and prognostic factors for non-small cell lung cancer. Lung Cancer. 1997 Jun;17 (Suppl 1):S3–10. doi: 10.1016/s0169-5002(97)00637-5. [DOI] [PubMed] [Google Scholar]
  8. Fergusson R. J., Gregor A., Dodds R., Kerr G. Management of lung cancer in South East Scotland. Thorax. 1996 Jun;51(6):569–574. doi: 10.1136/thx.51.6.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Humphrey E. W., Smart C. R., Winchester D. P., Steele G. D., Jr, Yarbro J. W., Chu K. C., Triolo H. H. National survey of the pattern of care for carcinoma of the lung. J Thorac Cardiovasc Surg. 1990 Dec;100(6):837–843. [PubMed] [Google Scholar]
  10. Janssen-Heijnen M. L., Gatta G., Forman D., Capocaccia R., Coebergh J. W. Variation in survival of patients with lung cancer in Europe, 1985-1989. EUROCARE Working Group. Eur J Cancer. 1998 Dec;34(14 Spec No):2191–2196. doi: 10.1016/s0959-8049(98)00312-8. [DOI] [PubMed] [Google Scholar]
  11. Kendrick S., Clarke J. The Scottish Record Linkage System. Health Bull (Edinb) 1993 Mar;51(2):72–79. [PubMed] [Google Scholar]
  12. Kesson E., Bucknall C. E., McAlpine L. G., Milroy R., Hole D., Vernon D. R., Macbeth F., Gillis C. R. Lung cancer--management and outcome in Glasgow, 1991-92. Br J Cancer. 1998 Nov;78(10):1391–1395. doi: 10.1038/bjc.1998.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Maher E. J., Timothy A., Squire C. J., Goodman A., Karp S. J., Paine C. H., Ryall R., Read G. Audit: the use of radiotherapy for NSCLC in the UK. Clin Oncol (R Coll Radiol) 1993;5(2):72–79. doi: 10.1016/s0936-6555(05)80850-7. [DOI] [PubMed] [Google Scholar]
  14. McLean A. N., Semple P. A., Franklin D. H., Petrie G., Millar E. A., Douglas J. G. The Scottish multi-centre prospective study of bronchoscopy for bronchial carcinoma and suggested audit standards. Respir Med. 1998 Sep;92(9):1110–1115. doi: 10.1016/s0954-6111(98)90403-6. [DOI] [PubMed] [Google Scholar]
  15. Pignon J. P., Arriagada R., Ihde D. C., Johnson D. H., Perry M. C., Souhami R. L., Brodin O., Joss R. A., Kies M. S., Lebeau B. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992 Dec 3;327(23):1618–1624. doi: 10.1056/NEJM199212033272302. [DOI] [PubMed] [Google Scholar]
  16. Stroner P. L., Brewster D. H., Dewar J. A., Eremin O., Gould A., Howard G. C., Kaye S. B. In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model. Br J Cancer. 1999 Apr;79(11-12):1641–1645. doi: 10.1038/sj.bjc.6690262. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES